Oxford Nanopore Technologies plc (FRA:4R0)

Germany flag Germany · Delayed Price · Currency is EUR
1.462
+0.036 (2.52%)
Last updated: Dec 3, 2025, 3:29 PM CET
-24.79%
Market Cap 1.38B
Revenue (ttm) 238.79M
Net Income (ttm) -167.16M
Shares Out n/a
EPS (ttm) -0.18
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 213
Open 1.390
Previous Close 1.426
Day's Range 1.390 - 1.474
52-Week Range 1.056 - 2.570
Beta n/a
RSI 41.63
Earnings Date Dec 3, 2025

About FRA:4R0

Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows the real-time analysis of DNA or RNA. It offers MinION Mk 1D, a portable device for DNA and RNA; GridION and GridION Q, a compact bench top device, which delivers a version of hardware, software, and chemistry. The company also provides PromethION 2 Solo, PromethION 2, PromethION 24, and PromethION 48. Its platform enables its cu... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2005
Employees 1,382
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 4R0
Full Company Profile

Financial Performance

In 2024, FRA:4R0's revenue was 183.19 million, an increase of 7.97% compared to the previous year's 169.67 million. Losses were -146.19 million, -5.38% less than in 2023.

Financial numbers in GBP Financial Statements

News

There is no news available yet.